Source: Health Canada shortage reports · Updated Jul 29, 2026
Some Lurasidone products are in shortage in Canada (1 of 19 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
An antipsychotic used to treat schizophrenia and bipolar depression.
Products affected
1 / 19
In shortage since
Mar 1, 2026
Est. full return
Aug 7, 2026
Reports on file
34
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TARO-LURASIDONE
120MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02504537 · since Mar 1, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Anticipated
LATUDA
80MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02387778 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Anticipated
LATUDA
60MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02413361 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Anticipated
LATUDA
40MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02387751 · ended Jun 30, 2026 · Requirements related to complying with good manufacturing practices.
Anticipated
LATUDA
20MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02422050 · ended Jun 30, 2026 · Business reasons
Discontinued
LATUDA
40MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02387751
To be discontinued
LATUDA
20MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02422050
To be discontinued
LATUDA
20MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02422050
To be discontinued
LATUDA
20MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02422050
To be discontinued
LATUDA
80MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02387778
To be discontinued
LATUDA
60MG · TABLET · SUMITOMO PHARMA CANADA, INC.
DIN 02413361
Resolved
TARO-LURASIDONE
60MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02504510 · ended Dec 19, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 34 reports. All reports are on file with Health Canada.
What's happening
Lurasidone is currently affected by an active shortage report filed with Health Canada by TARO PHARMACEUTICALS INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Lurasidone is classified under “ANTIPSYCHOTICS” (ATC N05AE).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Jul 24, 2026 → Aug 7, 2026
Jul 14, 2026
Estimated end date pushed back : Jun 19, 2026 → Jul 24, 2026
Common questions
What is Lurasidone used for?
An antipsychotic used to treat schizophrenia and bipolar depression.
When will Lurasidone be back in stock in Canada?
The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Lurasidone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antipsychotics)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.